share_log

国信证券股份有限公司关于申联生物医药(上海)股份有限公司首次公开发行股票并在科创板上市之保荐总结报告书

Guoxin Securities Co., Ltd.\'s sponsorship summary report on Shenlian Biomedical (Shanghai) Co., Ltd.\'s initial public offering of shares and listing on the Science and Technology Innovation Board

SZSI ·  May 9, 2023 11:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more